Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents

Details for Australian Patent Application No. 2005230916 (hide)

Owner The Board of Trustees of the Leland Stanford Junior University

Inventors Swartz, James Robert; Voloshin, Alexei M.

Agent FB Rice

Pub. Number AU-B-2005230916

PCT Pub. Number WO2005/098048

Priority 60/556,736 25.03.04 US

Filing date 21 March 2005

Wipo publication date 20 October 2005

Acceptance publication date 8 March 2012

International Classifications

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C12N 15/00 (2006.01) Mutation or genetic engineering

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

C12P 21/00 (2006.01) Preparation of peptides or proteins

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/098048 Priority application(s): WO2005/098048

8 March 2012 Application Accepted

  Published as AU-B-2005230916

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230922-Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1oxido4-quinolinyl)oxy}ethyl}-6h-dipyrido(3,2-b :2',3'-e)(1,4)diazepin-6-one

2005230915-Compounds and methods for treating dyslipidemia